Adrienne Monson – Lifestyle
Author:
AlzeCure Pharma
Last Patient has Completed AlzeCure’s Phase Ib Clinical Study with NeuroRestore ACD856
April 20, 2026
AlzeCure Pharma Publishes its Annual Report for 2025
April 8, 2026
AlzeCure Pharma to Present at Redeye Healthcare Day on April 14
April 7, 2026
AlzeCure Pharma to Present at Redeye Alzheimer’s Theme Event on April 9
April 1, 2026
AlzeCure Presents New Preclinical Data with NeuroRestore ACD856 at the Alzheimer’s Conference AD/PD
March 19, 2026